UBS Group’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $925K | Sell |
547,209
-63,594
| -10% | -$113K | ﹤0.01% | 5609 |
|
|
2025
Q4 | $867K | Sell |
610,803
-185,138
| -23% | -$270K | ﹤0.01% | 5696 |
|
|
2025
Q3 | $1.31M | Buy |
795,941
+221,410
| +39% | +$246K | ﹤0.01% | 5334 |
|
|
2025
Q2 | $420K | Buy |
574,531
+205,580
| +56% | +$177K | ﹤0.01% | 6155 |
|
|
2025
Q1 | $298K | Sell |
368,951
-340,048
| -48% | -$391K | ﹤0.01% | 6249 |
|
|
2024
Q4 | $978K | Buy |
708,999
+535,830
| +309% | +$601K | ﹤0.01% | 5312 |
|
|
2024
Q3 | $180K | Sell |
173,169
-12,371
| -7% | -$17K | ﹤0.01% | 5951 |
|
|
2024
Q2 | $321K | Buy |
185,540
+63,670
| +52% | +$128K | ﹤0.01% | 5335 |
|
|
2024
Q1 | $291K | Sell |
121,870
-22,456
| -16% | -$55.3K | ﹤0.01% | 5590 |
|
|
2023
Q4 | $481K | Sell |
144,326
-164,785
| -53% | -$441K | ﹤0.01% | 5141 |
|
|
2023
Q3 | $1.16M | Buy |
309,111
+306,958
| +14,257% | +$1.42M | ﹤0.01% | 3940 |
|
|
2023
Q2 | $9.19K | Sell |
2,153
-203,259
| -99% | -$1.2M | ﹤0.01% | 7189 |
|
|
2023
Q1 | $1.41M | Sell |
205,412
-100,237
| -33% | -$778K | ﹤0.01% | 3791 |
|
|
2022
Q4 | $2.42M | Buy |
305,649
+260,697
| +580% | +$2.01M | ﹤0.01% | 3206 |
|
|
2022
Q3 | $432K | Sell |
44,952
-71,146
| -61% | -$720K | ﹤0.01% | 4467 |
|
|
2022
Q2 | $841K | Buy |
116,098
+12,237
| +12% | +$106K | ﹤0.01% | 3868 |
|
|
2022
Q1 | $1.34M | Sell |
103,861
-59,831
| -37% | -$761K | ﹤0.01% | 3817 |
|
|
2021
Q4 | $2.61M | Buy |
163,692
+40,930
| +33% | +$716K | ﹤0.01% | 3497 |
|
|
2021
Q3 | $1.97M | Buy |
122,762
+70,178
| +133% | +$1.03M | ﹤0.01% | 3586 |
|
|
2021
Q2 | $727K | Sell |
52,584
-68,638
| -57% | -$972K | ﹤0.01% | 4449 |
|
|
2021
Q1 | $1.77M | Buy |
121,222
+108,462
| +850% | +$1.84M | ﹤0.01% | 3680 |
|
|
2020
Q4 | $221K | Sell |
12,760
-3,475
| -21% | -$61.9K | ﹤0.01% | 5180 |
|
|
2020
Q3 | $298K | Sell |
16,235
-7,919
| -33% | -$147K | ﹤0.01% | 4549 |
|
|
2020
Q2 | $431K | Buy |
24,154
+3,352
| +16% | +$56.7K | ﹤0.01% | 4268 |
|
|
2020
Q1 | $338K | Sell |
20,802
-9,759
| -32% | -$180K | ﹤0.01% | 4310 |
|
|
2019
Q4 | $550K | Sell |
30,561
-2,722
| -8% | -$50.2K | ﹤0.01% | 4761 |
|
|
2019
Q3 | $674K | Sell |
33,283
-33,141
| -50% | -$662K | ﹤0.01% | 4301 |
|
|
2019
Q2 | $1.47M | Buy |
66,424
+39,794
| +149% | +$691K | ﹤0.01% | 3418 |
|
|
2019
Q1 | $363K | Sell |
26,630
-181,404
| -87% | -$2.42M | ﹤0.01% | 4259 |
|
|
2018
Q4 | $1.88M | Buy |
208,034
+179,492
| +629% | +$2.08M | ﹤0.01% | 3094 |
|
|
2018
Q3 | $471K | Buy |
28,542
+11,679
| +69% | +$207K | ﹤0.01% | 4451 |
|
|
2018
Q2 | $236K | Sell |
16,863
-64,039
| -79% | -$917K | ﹤0.01% | 4824 |
|
|
2018
Q1 | $894K | Buy |
80,902
+70,000
| +642% | +$766K | ﹤0.01% | 3802 |
|
|
2017
Q4 | $96K | Sell |
10,902
-7,083
| -39% | -$75.8K | ﹤0.01% | 5378 |
|
|
2017
Q3 | $239K | Buy |
17,985
+6,148
| +52% | +$81.3K | ﹤0.01% | 4723 |
|
|
2017
Q2 | $171K | Buy |
11,837
+9,107
| +334% | +$175K | ﹤0.01% | 4839 |
|
|
2017
Q1 | $58K | Sell |
2,730
-16,251
| -86% | -$400K | ﹤0.01% | 5415 |
|
|
2016
Q4 | $534K | Buy |
18,981
+14,150
| +293% | +$396K | ﹤0.01% | 4058 |
|
|
2016
Q3 | $129K | Buy |
4,831
+871
| +22% | +$23.8K | ﹤0.01% | 4839 |
|
|
2016
Q2 | $67K | Buy |
+3,960
| New | +$74.3K | ﹤0.01% | 5302 |
|
|
2016
Q1 | – | Sell |
-605
| Closed | -$14K | – | 7670 |
|
|
2015
Q4 | $14K | Buy |
+605
| New | +$15.6K | ﹤0.01% | 7049 |
|
|
2015
Q3 | – | Sell |
-2,777
| Closed | -$80K | – | 8426 |
|
|
2015
Q2 | $80K | Buy |
2,777
+226
| +9% | +$5.71K | ﹤0.01% | 5587 |
|
|
2015
Q1 | $78K | Buy |
2,551
+1,866
| +272% | +$48.2K | ﹤0.01% | 5625 |
|
|
2014
Q4 | $11K | Buy |
+685
| New | +$9.66K | ﹤0.01% | 8294 |
|
Other funds holding CHRS
VCM
SB
KKRC
CM
CWG